ARTICLE | Clinical News
Jentadueto XR linagliptin/metformin extended release regulatory update
June 6, 2016 7:00 AM UTC
FDA approved an NDA from Boehringer for Jentadueto XR linagliptin/metformin extended release as an adjunct to diet and exercise to improve glycemic control in adult Type II diabetics when treatment wi...